About the Trial

** Recruitment not started due to lack of funding **

The CRASH-19 trial will assess the effectiveness and safety of supportive care interventions for patients hospitalised with suspected or confirmed acute COVID-19 infection with a focus on cardiac and pulmonary protection. We will evaluate the effects of aspirin, the angiotensin receptor blocker losartan, and simvastatin compared with standard care.

Read more….

CRASH-19 Numbers

Number of Participating Countries
Number of Participating Hospitals
Number of Patients Randomised

Latest News